GB0616111D0 - Agents, methods and uses - Google Patents

Agents, methods and uses

Info

Publication number
GB0616111D0
GB0616111D0 GBGB0616111.1A GB0616111A GB0616111D0 GB 0616111 D0 GB0616111 D0 GB 0616111D0 GB 0616111 A GB0616111 A GB 0616111A GB 0616111 D0 GB0616111 D0 GB 0616111D0
Authority
GB
United Kingdom
Prior art keywords
agents
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0616111.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Ardana Bioscience Ltd
Original Assignee
Medical Research Council
Ardana Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council, Ardana Bioscience Ltd filed Critical Medical Research Council
Priority to GBGB0616111.1A priority Critical patent/GB0616111D0/en
Publication of GB0616111D0 publication Critical patent/GB0616111D0/en
Priority to US12/308,482 priority patent/US9388216B2/en
Priority to JP2009514867A priority patent/JP5290163B2/ja
Priority to PCT/GB2007/001586 priority patent/WO2007144554A2/en
Priority to CN201210447203.6A priority patent/CN102977188B/zh
Priority to EP07732620.5A priority patent/EP2029618B1/en
Priority to CN200780026537.3A priority patent/CN101553500B/zh
Priority to JP2012219710A priority patent/JP2013056883A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0616111.1A 2006-06-16 2006-08-12 Agents, methods and uses Ceased GB0616111D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0616111.1A GB0616111D0 (en) 2006-06-16 2006-08-12 Agents, methods and uses
US12/308,482 US9388216B2 (en) 2006-06-16 2007-05-01 Methods of treating reproductive cancer
JP2009514867A JP5290163B2 (ja) 2006-06-16 2007-05-01 薬剤、方法および使用
PCT/GB2007/001586 WO2007144554A2 (en) 2006-06-16 2007-05-01 Gnrh (gonadotropin-releasing hormone) peptide variants
CN201210447203.6A CN102977188B (zh) 2006-06-16 2007-05-01 Gnrh(促性腺激素释放激素)肽衍生物
EP07732620.5A EP2029618B1 (en) 2006-06-16 2007-05-01 Agents, methods and uses
CN200780026537.3A CN101553500B (zh) 2006-06-16 2007-05-01 Gnrh(促性腺激素释放激素)肽衍生物
JP2012219710A JP2013056883A (ja) 2006-06-16 2012-10-01 薬剤、方法および使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80504206P 2006-06-16 2006-06-16
US80518106P 2006-06-19 2006-06-19
GBGB0616111.1A GB0616111D0 (en) 2006-06-16 2006-08-12 Agents, methods and uses
US12/308,482 US9388216B2 (en) 2006-06-16 2007-05-01 Methods of treating reproductive cancer
PCT/GB2007/001586 WO2007144554A2 (en) 2006-06-16 2007-05-01 Gnrh (gonadotropin-releasing hormone) peptide variants

Publications (1)

Publication Number Publication Date
GB0616111D0 true GB0616111D0 (en) 2006-09-20

Family

ID=38626706

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0616111.1A Ceased GB0616111D0 (en) 2006-06-16 2006-08-12 Agents, methods and uses

Country Status (6)

Country Link
US (1) US9388216B2 (enExample)
EP (1) EP2029618B1 (enExample)
JP (2) JP5290163B2 (enExample)
CN (2) CN102977188B (enExample)
GB (1) GB0616111D0 (enExample)
WO (1) WO2007144554A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864398B (zh) * 2009-09-03 2012-11-14 李吉祐 一种抗促性腺激素释放激素受体的单克隆抗体与应用
US20120004182A1 (en) * 2010-07-02 2012-01-05 Carsten Gruendker Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
EP2447276A1 (en) * 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
CN102675420B (zh) * 2011-03-17 2014-08-27 屏东科技大学 一种促进鱼类卵黄生成的合成胜肽及其用途
CN108524919A (zh) 2012-05-17 2018-09-14 延伸生物科学股份有限公司 用于改进的药物递送的载体
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates
US9789197B2 (en) 2014-10-22 2017-10-17 Extend Biosciences, Inc. RNAi vitamin D conjugates
WO2016065042A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
US9526768B2 (en) 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer
CN110431147A (zh) * 2017-01-20 2019-11-08 免疫系统调节控股有限公司 新化合物(免疫刺激肽-细胞内感染)
WO2018134370A1 (en) * 2017-01-20 2018-07-26 Immune System Regulation Holding Ab Novel compounds (immunorhelins)
CN110381977A (zh) 2017-01-20 2019-10-25 免疫系统调节控股有限公司 已知化合物的治疗细胞内感染的新用途
WO2018153961A1 (en) 2017-02-22 2018-08-30 Immune System Regulation Holding Ab Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics
CN107995138B (zh) * 2017-12-29 2020-10-23 中国电子科技集团公司第二十研究所 Sccpm系统的联合迭代载波同步与解调方法
CN111875673B (zh) * 2020-07-31 2022-03-11 江苏莱森生物科技研究院有限公司 一种具有抗肿瘤活性的多肽及其用途
CN115326937B (zh) * 2021-05-11 2024-06-18 山东省食品药品检验研究院 一种基因毒杂质捕捉用固相探针及其使用方法与应用
JP2025534350A (ja) 2022-09-30 2025-10-15 エクステンド バイオサイエンシズ インコーポレーテッド 長時間作用型副甲状腺ホルモン

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2029018A1 (en) 1989-11-01 1991-05-02 Robert P. Millar Analogues of gonadotropin releasing hormone
PT769956E (pt) * 1994-07-22 2000-07-31 Hampton Roads Medical College Utilizacao de antagonistas de gnrh para a preparacao de medicamentos para o tratamento de condicoes dependentes de gonado-esteroides
US6664369B1 (en) * 1994-08-10 2003-12-16 Creighton University GnRH analogues with antitumour effects and pharmaceutical compositions thereof
CN1179181A (zh) * 1995-02-10 1998-04-15 萨斯喀彻温大学 GnRH－白细胞毒素嵌合体
DE69737635T2 (de) * 1996-08-30 2008-01-03 Peptech Ltd., North Ryde Formulierung zur verzögerten Freisetzung von Peptidagonisten und -analoga des GnRH
GB2343182A (en) 1998-10-27 2000-05-03 Ferring Bv Use of GnRH-II and analogues thereof for the treatment of osteoporosis
GB2344287A (en) 1998-12-03 2000-06-07 Ferring Bv Controlled release pharmaceutical formulation
US6323179B1 (en) 1999-10-15 2001-11-27 Theresa Siler-Khodr Chicken GNRH analogs and uses thereof in regulation of fertility and pregnancy
US7109171B2 (en) 2000-02-28 2006-09-19 Praecis Pharmaceuticals Inc. Methods for treating FSH related conditions with GnRH antagonists
US7834141B1 (en) 2000-03-31 2010-11-16 Theresa Siler-Khodr Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
US20040152639A1 (en) 2001-08-28 2004-08-05 Siler-Khodr Theresa M. Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
WO2003093304A1 (en) 2002-05-03 2003-11-13 Neurogenex Co., Ltd. Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof
GB2397649B (en) * 2002-07-22 2005-12-21 Ardana Bioscience Ltd Screening method and anti-tumor drug candidate obtained therefrom

Also Published As

Publication number Publication date
JP2013056883A (ja) 2013-03-28
US9388216B2 (en) 2016-07-12
CN102977188A (zh) 2013-03-20
EP2029618B1 (en) 2015-08-12
JP2009539952A (ja) 2009-11-19
EP2029618A2 (en) 2009-03-04
JP5290163B2 (ja) 2013-09-18
WO2007144554A3 (en) 2008-02-14
US20100234303A1 (en) 2010-09-16
CN102977188B (zh) 2015-07-15
CN101553500B (zh) 2014-01-01
CN101553500A (zh) 2009-10-07
WO2007144554A2 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
ZA200810323B (en) Fkbp-l and uses thereof
PL2064327T3 (pl) Dbait i ich zastosowania
GB2444853B (en) Methods & uses
IL183740A0 (en) Cyclohexylamides as dopamine d3, d2 and
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
GB0601143D0 (en) Uses, methods and compositions
ZA200903906B (en) Carboranylporphyrins and uses thereof
ZA200807944B (en) Skin lightening agents, compositions and methods
ZA200807945B (en) Skin lightening agents, compositions and methods
GB0616111D0 (en) Agents, methods and uses
GB0719592D0 (en) Compound, use and method
PL2026863T3 (pl) Jednostka podająca i sposób podawania
GB0600967D0 (en) Methods
GB0613209D0 (en) Methods
IL194689A0 (en) Agent, composition and method
GB0607562D0 (en) Method, composition and use
IL177759A0 (en) Cospeptin, cosmedin and their uses
GB0608941D0 (en) Methods
GB0707069D0 (en) Methods and uses
GB0719834D0 (en) Compounds, method and use
GB0610059D0 (en) Uses and methods
GB0705057D0 (en) Agents, method and uses
GB0606794D0 (en) Methods and uses
GB2444960B (en) Combined pseudoscope and hyperscope
GB0621665D0 (en) Blogmail and podmail

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)